Practical reading from Professor Paul Lee and the Lincolnshire Hip Clinic team — across hip replacement, Arthrosamid, ChondroFiller, PRP and the wider world of hip and groin pain.
ChondroFiller injection scaffolds a focal cartilage defect for cellular remodelling; hyaluronic acid lubricates the entire joint when wear is diffuse. These opposite mechanisms treat opposite pathologies, and imaging—not patient preference—determines which, if either, is appropriate.
A collagen scaffold injected under ultrasound, ChondroFiller self-gels within the hip joint to support repair of focal cartilage damage (Grade III–IV). The £2,995 treatment sits outside NHS commissioning and requires four to six weeks of protected loading after injection.
Gluteal tendon compression at the greater trochanter drives lateral hip pain, most common in women aged 40–60; more than 90% of cases resolve within 6–12 months of progressive exercise and load management.
Hip cartilage cannot self-heal because it lacks blood supply. AMIC combines microfracture—releasing bone marrow stem cells—with a collagen scaffold that shields the clot from joint shear forces, achieving 99.6% success with zero hip replacements needed, versus 2–33% in microfracture alone.
ChondroFiller, an injectable collagen scaffold, recruits the patient's own progenitor cells to regenerate cartilage in the hip joint. For patients with focal, contained cartilage defects in early-stage osteoarthritis, manufacturer data document approximately 30-point improvement on the Harris Hip Score, extending the joint's working life before replacement becomes necessary.
Cartilage defect area—measured in square centimetres—directly determines which hip repair technique is viable. Defects under 2 cm² suit autograft transfer; those between 2–4 cm² respond to injectable scaffold; larger lesions require allograft transplantation. Pain alone is an unreliable guide to either severity or treatment options.
ChondroFiller™ is a cell-free collagen scaffold that, once injected into the hip joint, draws the patient's own progenitor cells to rebuild damaged cartilage; published studies show functional improvement averaging 33 points on the Harris Hip Score.
Cartilage in the hip joint thins and underlying bone undergoes remodelling months or years before osteoarthritis causes constant pain; intermittent discomfort reflects structural changes that plain X-rays cannot yet detect.
ChondroFiller places an acellular collagen scaffold into focal cartilage defects; PRP is produced by centrifuging blood to concentrate growth factors. These operate via different mechanisms—one structural, one biological—suited to different presentations of hip damage.
Lincolnshire Hip Clinic
Led by Professor Paul Lee
Start with a free, non-medical discovery call with our team. We will tell you, honestly, which of our pathways — surgical or non-surgical — fits your situation. No GP referral, no pressure to proceed.
What we offer
